2022-11-15
2022-11-25
2022-12-11
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2024-01-03
2023-04-21
收益超10亿美元,剑指肿瘤治疗!Scribe与赛诺菲启动基于基因编辑的NK细胞疗法合作
2022-11-17
2023-12-21
2022-11-23
拿下FDA许可,Prenetics(PRE.US)推开肿瘤基因检测个性化大门
2023-01-16
2023-02-08
2023-04-06